Download FREE Report Sample
Download Free sampleThe deproteinized calf blood extract is a sterile solution containing inorganic substance and small molecule organic substance made from fresh calf blood or serum by deproteinization, concentration, ultrafiltration or dialysis.
Actovegin Market contains market size and forecasts of Actovegin in Global, including the following market information:
Global Actovegin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Actovegin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Intravenous Drip Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Actovegin include Nycomed (Takeda Pharmaceutical), Heilongjiang Jiangshi Pharmaceutical, Jilin Connell Pharmaceutical, Harbin Shengtai Biopharmaceutical, Wuhan Renfu Pharmaceutical, Hunan Wuzhoutong Pharmaceutical, Heilongjiang Zhenbao Island Pharmaceutical, Jinzhou Aohong Pharmaceutical Co. LTD and Wuhan Hualong Biopharmaceutical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Actovegin companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Actovegin Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Actovegin Market Segment Percentages, by Type, 2021 (%)
Intravenous Drip
Arterial Injection
Intramuscular Injection
Bladder Perfusion
Oral Medicine
Local Drug Delivery
Global Actovegin Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Actovegin Market Segment Percentages, by Application, 2021 (%)
Adult
Teenagers
Infants and Young Children
Other
Global Actovegin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Actovegin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Actovegin revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Actovegin revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nycomed (Takeda Pharmaceutical)
Heilongjiang Jiangshi Pharmaceutical
Jilin Connell Pharmaceutical
Harbin Shengtai Biopharmaceutical
Wuhan Renfu Pharmaceutical
Hunan Wuzhoutong Pharmaceutical
Heilongjiang Zhenbao Island Pharmaceutical
Jinzhou Aohong Pharmaceutical Co. LTD
Wuhan Hualong Biopharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
